These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26467770)

  • 1. A novel bioreactor and culture method drives high yields of platelets from stem cells.
    Avanzi MP; Oluwadara OE; Cushing MM; Mitchell ML; Fischer S; Mitchell WB
    Transfusion; 2016 Jan; 56(1):170-8. PubMed ID: 26467770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
    Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
    Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo large-scale generation of human platelets from cord blood CD34+ cells.
    Matsunaga T; Tanaka I; Kobune M; Kawano Y; Tanaka M; Kuribayashi K; Iyama S; Sato T; Sato Y; Takimoto R; Takayama T; Kato J; Ninomiya T; Hamada H; Niitsu Y
    Stem Cells; 2006 Dec; 24(12):2877-87. PubMed ID: 16960134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a co-culture system for effective megakaryo/thrombopoiesis from umbilical cord blood hematopoietic stem/progenitor cells.
    Hatami J; Andrade PZ; Alves de Matos AP; Djokovic D; Lilaia C; Ferreira FC; Cabral JM; da Silva CL
    Cytotherapy; 2015 Apr; 17(4):428-42. PubMed ID: 25680300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs can increase the efficiency of ex vivo platelet generation.
    Emmrich S; Henke K; Hegermann J; Ochs M; Reinhardt D; Klusmann JH
    Ann Hematol; 2012 Nov; 91(11):1673-84. PubMed ID: 22763947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.
    Figueiredo C; Blaszczyk R
    J Stem Cells; 2014; 9(3):149-61. PubMed ID: 25157449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
    Cheng L; Qasba P; Vanguri P; Thiede MA
    J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture system.
    Shaw PH; Gilligan D; Wang XM; Thall PF; Corey SJ
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):151-6. PubMed ID: 12652464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
    Proulx C; Boyer L; Hurnanen DR; Lemieux R
    J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice.
    Patel A; Clementelli CM; Jarocha D; Mosoyan G; Else C; Kintali M; Fong H; Tong J; Gordon R; Gillespie V; Keyzner A; Poncz M; Hoffman R; Iancu-Rubin C
    Transfusion; 2019 Dec; 59(12):3698-3713. PubMed ID: 31802511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
    De Bruyn C; Delforge A; Martiat P; Bron D
    Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo megakaryocyte expansion and platelet production from human cord blood stem cells.
    Cortin V; Pineault N; Garnier A
    Methods Mol Biol; 2009; 482():109-26. PubMed ID: 19089352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.
    Ahmed N; Khokher MA; Hassan HT
    Stem Cells; 1999; 17(2):92-9. PubMed ID: 10195569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a Multichannel Bioreactor with a Collagen Scaffold, ECM, and Cryoprecipitate to Significantly Produce Platelets from Umbilical Cord Blood Stem Cells.
    Derakhty Gonbad MH; Khoshfetrat AB; Movassaghpour AA; Sanaat Z; Nozad Charoudeh H
    Int J Hematol Oncol Stem Cell Res; 2023 Oct; 17(4):245-256. PubMed ID: 38076776
    [No Abstract]   [Full Text] [Related]  

  • 16. Megakaryocyte and platelet production from human cord blood stem cells.
    Robert A; Cortin V; Garnier A; Pineault N
    Methods Mol Biol; 2012; 788():219-47. PubMed ID: 22130711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale generation of megakaryocytes from human embryonic stem cells using transgene-free and stepwise defined suspension culture conditions.
    Zhang B; Wu X; Zi G; He L; Wang S; Chen L; Fan Z; Nan X; Xi J; Yue W; Wang L; Wang L; Hao J; Pei X; Li Y
    Cell Prolif; 2021 Apr; 54(4):e13002. PubMed ID: 33615584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of human cord blood CD34+ hematopoietic stem cell differentiation to megakaryocyte on aminated PES nanofiber scaffold compare to 2-D culture system.
    Sabaghi F; Shamsasenjan K; Movasaghpour AA; Amirizadeh N; Nikougoftar M; Bagheri N
    Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1062-8. PubMed ID: 25761536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets.
    Li J; Luo J; Luo YQ; Zhou M; Zhao L; Yao LJ; Dong H; Yang RN
    Transfusion; 2014 Aug; 54(8):2106-17. PubMed ID: 24655355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.